» Articles » PMID: 15449054

Influence of Age on Adenomatous Polyposis Coli and P53 Mutation Frequency in Sporadic Colorectal Cancer-rarity of Co-occurrence of Mutations in APC, K-ras, and P53 Genes

Overview
Journal Virchows Arch
Date 2004 Sep 28
PMID 15449054
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Previous studies have investigated the possibility that specific mutations may be related to specific clinicopathological features. However, most previous investigations included only an average age (40-80 years) group of sporadic colorectal cancers and, moreover, studied only a single gene in isolation. Therefore, the influence of age on these mutation frequencies remains unclear, despite age being considered a risk factor for genetic mutation.

Materials And Methods: This study included 122 sporadic colorectal cancers from three different age groups and analyzed mutation frequencies of adenomatous polyposis coli (APC), K-ras, and p53 genes and microsatellite instability to determine their mutation frequencies and relationships with clinicopathological features.

Results: Significantly lower p53 mutation frequencies were observed among young (32 years old or younger) and old (86 years old or older) patient groups compared with an average age (39-85 years old) patient group (14.3% and 19.2% versus 51.5%, P<0.001). APC mutation frequency (11.8%) was significantly lower in highly aggressive (Dukes' stage D) tumors ( P=0.003) than in the other stage tumors (Dukes' stage A, B, and C). Additionally, simultaneous occurrence of all three genetic alterations in an individual tumor was rare (below 5%). Statistical analysis further confirmed that mutation number in Dukes' D tumors occurred less frequently than expected in other stage tumors ( P=0.008).

Conclusions: Genetic alterations of sporadic colorectal cancers have different relationships with age or tumor stage. Additionally, most sporadic colorectal tumors do not necessarily require following the widely accepted genetic model, because the three key genetic mutations, APC, K-ras, and p53, rarely occur simultaneously.

Citing Articles

The role of kras mutations and MSI status in diagnosis of colorectal cancer.

Irani Shemirani A, Montazer Haghighi M, Milanizadeh S, Taleghani M, Fatemi S, Damavand B Gastroenterol Hepatol Bed Bench. 2014; 4(2):70-5.

PMID: 24834160 PMC: 4017411.


Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.

Ines C, Donia O, Rahma B, Ammar A, Sameh A, Khalfallah T Tumour Biol. 2014; 35(7):7163-75.

PMID: 24763823 DOI: 10.1007/s13277-014-1874-4.


RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy.

Yajima I, Kumasaka M, Thang N, Goto Y, Takeda K, Yamanoshita O Dermatol Res Pract. 2011; 2012:354191.

PMID: 22013435 PMC: 3195305. DOI: 10.1155/2012/354191.


Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.

Miranda E, Destro A, Malesci A, Balladore E, Bianchi P, Baryshnikova E Br J Cancer. 2006; 95(8):1101-7.

PMID: 16969349 PMC: 2360724. DOI: 10.1038/sj.bjc.6603337.

References
1.
van der Luijt R, Khan P, Vasen H, van Leeuwen C, Tops C, Roest P . Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. Genomics. 1994; 20(1):1-4. DOI: 10.1006/geno.1994.1119. View

2.
Samowitz W, Curtin K, Ma K, Edwards S, Schaffer D, Leppert M . Prognostic significance of p53 mutations in colon cancer at the population level. Int J Cancer. 2002; 99(4):597-602. DOI: 10.1002/ijc.10405. View

3.
Goh H, Chan C, Khine K, Smith D . p53 and behaviour of colorectal cancer. Lancet. 1994; 344(8917):233-4. DOI: 10.1016/s0140-6736(94)93000-7. View

4.
Chiang J, Chou Y, Chen T, Ng K, Lin J . Nuclear beta-catenin expression is closely related to ulcerative growth of colorectal carcinoma. Br J Cancer. 2002; 86(7):1124-9. PMC: 2364167. DOI: 10.1038/sj.bjc.6600214. View

5.
De Filippo C, Luceri C, Caderni G, Pacini M, Messerini L, Biggeri A . Mutations of the APC gene in human sporadic colorectal cancers. Scand J Gastroenterol. 2002; 37(9):1048-53. DOI: 10.1080/003655202320378248. View